AGT and cardiac hypertrophy: The renin-angiotensin system (RAS) and Ang II, a key active peptide in RAS, have been shown to be closely associated with cardiac hypertrophy and fibrosis, which may be prevented by angiotensin-converting enzyme inhibitor (ACEI) or Ang II type 1 receptor blocker (ARB) treatment (11,12).